| View |
|
DRP-13674-04
|
Ampicillin (as sodium)
|
Gopicin
|
250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Uni Medicolabs, Inc.
|
India
|
CLIDP Conversion
|
08 March 2024
|
24 March 2028
|
| View |
|
DRP-13686-04
|
Losartan Potassium
|
Arteva 100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
28 March 2028
|
| View |
|
DRP-13686-05
|
Losartan Potassium
|
Technozar
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 March 2024
|
08 March 2028
|
| View |
|
DRP-13687-04
|
Losartan Potassium
|
Technozar
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 March 2024
|
28 March 2028
|
| View |
|
DRP-13689-02
|
Ceftazidime (as pentahydrate)
|
Tazidime
|
1 g
|
Powder for Injection (I.V/I.M.)
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals, Pvt. Ltd.
|
Pakistan
|
CLIDP Conversion
|
17 March 2024
|
05 March 2029
|
| View |
|
DRP-13776-01
|
Apixaban
|
Apiklot
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Unison Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
17 April 2028
|
| View |
|
DRP-13845-01
|
Metformin Hydrochloride
|
Technomet
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (Biguanide)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 March 2024
|
28 April 2028
|
| View |
|
DRP-13869-01
|
Vildagliptin
|
None
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 March 2024
|
09 May 2028
|
| View |
|
DRP-13888-05
|
Iron (as Iron Sucrose)
|
None
|
20 mg/mL (100 mg/5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
11 May 2028
|
| View |
|
DRP-13888-06
|
Iron (as Iron Sucrose)
|
None
|
20 mg/mL (100 mg/5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur laboratories Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
11 May 2028
|
| View |
|
DRP-13919-01
|
Acetylcysteine
|
Amcetyl-600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Mascot Health Series Pvt. Ltd
|
India
|
CLIDP Conversion
|
25 March 2024
|
17 May 2028
|
| View |
|
DRP-13983-05
|
Apixaban
|
Carepixban
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 March 2024
|
31 May 2028
|
| View |
|
DRP-13984-04
|
Apixaban
|
None
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 March 2024
|
31 May 2028
|
| View |
|
DRP-14019-03
|
Co - Amoxiclav
|
Orapen S
|
457 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillins)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
13 March 2024
|
06 June 2028
|
| View |
|
DRP-14052-01
|
Ketoanalogues and Essential Amino Acids
|
Analou
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
08 June 2028
|
| View |
DRP-14067-01_PI_01.pdf
|
DRP-14067-01
|
Levothyroxine Sodium
|
Thyroxil
|
100 mcg
|
Tablet
|
Thyroid Hormone
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
09 June 2028
|
| View |
|
DRP-14088-05
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
None
|
3 mg/1 mg (0.3%/0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
20 June 2028
|
| View |
|
DRP-14091-02
|
Metformin Hydrochloride
|
Diamet
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose - Lowering Drug (Biguanide)
|
Mercury Laboratories Ltd.
|
India
|
CLIDP Conversion
|
04 April 2024
|
20 June 2028
|
| View |
|
DRP-14110-01
|
Capecitabine
|
Capeget
|
500 mg
|
Film-Coated Tablet
|
Antimetabolite (Pyrimidine analogue )
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
22 June 2028
|
| View |
|
DRP-14170-02
|
Enzalutamide
|
Enzagen
|
40 mg
|
Capsule
|
Androgen Receptor Antagonist
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
01 August 2028
|